These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10413408)

  • 21. Human papilloma-virus classified as carcinogenic.
    Mayor S
    BMJ; 1996 Jul; 313(7049):70. PubMed ID: 8688752
    [No Abstract]   [Full Text] [Related]  

  • 22. Understanding the epidemiology of genital infection with oncogenic and nononcogenic human papillomaviruses: a promising lead for primary prevention of cervical cancer.
    Franco EL
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):759-61. PubMed ID: 9332755
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of TP53 in Cervical carcinogenesis.
    Tommasino M; Accardi R; Caldeira S; Dong W; Malanchi I; Smet A; Zehbe I
    Hum Mutat; 2003 Mar; 21(3):307-12. PubMed ID: 12619117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus and skin cancer.
    McGregor JM; Rustin MH
    Postgrad Med J; 1994 Oct; 70(828):682-5. PubMed ID: 7831160
    [No Abstract]   [Full Text] [Related]  

  • 25. Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients--assessing their roles as human papillomavirus cofactors.
    Castle PE; Giuliano AR
    J Natl Cancer Inst Monogr; 2003; (31):29-34. PubMed ID: 12807942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer.
    zur Hausen H
    J Natl Cancer Inst; 2001 Feb; 93(4):252-3. PubMed ID: 11181763
    [No Abstract]   [Full Text] [Related]  

  • 27. [The role of viral infection with human papillomavirus-HPV in carcinogenesis of the uterine cervix].
    Kwaśniewska A
    Postepy Hig Med Dosw; 1997; 51(5):547-65. PubMed ID: 9489454
    [No Abstract]   [Full Text] [Related]  

  • 28. [The role of tumor-related papillomavirus infection of the genitals in the genesis of background pathology of the ectocervix, dysplasia and preinvasive cancer of the cervix uteri].
    Maksimov SIa; Savicheva AM; Bashmakova MA; Shaimardanova GI; Shipitsina EV; Rybina EV
    Vopr Onkol; 1999; 45(6):627-9. PubMed ID: 10703510
    [No Abstract]   [Full Text] [Related]  

  • 29. Cervical cancer: following the HPV pathway.
    McNeil C
    J Natl Cancer Inst; 1995 Sep; 87(18):1354-5. PubMed ID: 7658494
    [No Abstract]   [Full Text] [Related]  

  • 30. Relation between retinoblastoma and p53 proteins in human papilloma viruses 16/18 positive and negative cancers of the uterine cervix.
    Chetty R; Bramdev A; Aguirre-Arteta A; Pegoraro RJ; Sataar N
    J Clin Pathol; 1997 May; 50(5):413-6. PubMed ID: 9215125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between human papillomavirus type 18 variants and histopathology of cervical cancer.
    Lizano M; Berumen J; Guido MC; Casas L; García-Carrancá A
    J Natl Cancer Inst; 1997 Aug; 89(16):1227-31. PubMed ID: 9274919
    [No Abstract]   [Full Text] [Related]  

  • 32. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia.
    Schiffman MH; Castle P
    J Natl Cancer Inst; 2003 Mar; 95(6):E2. PubMed ID: 12644550
    [No Abstract]   [Full Text] [Related]  

  • 33. Papillomavirus and p53.
    zur Hausen H
    Nature; 1998 May; 393(6682):217. PubMed ID: 9607756
    [No Abstract]   [Full Text] [Related]  

  • 34. [Human papillomavirus and genital neoplasms].
    Sastre-Garau X
    Ann Pathol; 1998; 18(5 Suppl):75-6. PubMed ID: 9884761
    [No Abstract]   [Full Text] [Related]  

  • 35. [Molecular mechanism in carcinogenesis of the uterine cervix].
    Nakagawa S; Taketani Y
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():73-7. PubMed ID: 15535209
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.
    Abdulkarim B; Sabri S; Deutsch E; Chagraoui H; Maggiorella L; Thierry J; Eschwege F; Vainchenker W; Chouaïb S; Bourhis J
    Oncogene; 2002 Apr; 21(15):2334-46. PubMed ID: 11948417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re: Emerging technologies and cervical cancer.
    Cox JT; Koutsky L; Schiffman M; Solomon D
    J Natl Cancer Inst; 2000 Jun; 92(12):1014. PubMed ID: 10861315
    [No Abstract]   [Full Text] [Related]  

  • 38. Genital HPV: links to cervical cancer, treatment, and prevention.
    Perez LA
    Clin Lab Sci; 2001; 14(3):183-6; quiz 193. PubMed ID: 11517629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of human papillomavirus vaccines in cervical neoplasia.
    Stern PL; Faulkner R; Veranes EC; Davidson EJ
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):783-99. PubMed ID: 11563873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.
    Kurvinen K; Syrjänen K; Syrjänen S
    J Clin Oncol; 1996 Jul; 14(7):2120-30. PubMed ID: 8683245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.